According to Stratview Research, the HPV vaccines market was estimated at USD 6.51 billion in 2022 and is likely to grow at a CAGR of 16.05% during 2023-2028 to reach USD 15.94 billion in 2028. In the ever-evolving landscape of healthcare, the Human Papillomavirus (HPV) vaccines stand as guardians of health, wielding the power to prevent a range of diseases...